Cheviot Value Management, LLC Amgen Inc Transaction History

Cheviot Value Management, LLC

$927 Million
Q3 2025

A detailed history of Cheviot Value Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Cheviot Value Management, LLC holds 3,762 shares of AMGN stock, worth $1.11 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

3,762

Previous 3,762 -0.0%

Holding current value

$1.11 Million

Previous $1.05 Million 1.05%

% of portfolio

0.11%

Previous 0.12%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 08, 2025	BUY	$258.59 - $327.36 $1,034 - $1,309	4 Added 0.11%	3,762 $1.17 Million
Q3 2024 Nov 14, 2024	SELL	$309.38 - $337.38 $1,237 - $1,349	-4 Reduced 0.11%	3,758 $1.21 Million
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $3,941 - $4,789	15 Added 0.4%	3,762 $1.18 Million
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $63,925 - $72,115	-250 Reduced 6.25%	3,747 $1.08 Million
Q2 2023 Nov 07, 2023	BUY	$214.27 - $253.37 $2,571 - $3,040	12 Added 0.3%	3,997 $887,000
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $66,156 - $80,633	293 Added 7.94%	3,985 $963,000
Q1 2022 May 11, 2022	BUY	$219.27 - $242.57 $373,855 - $413,581	1,705 Added 85.81%	3,692 $893,000
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $849 - $994	-4 Reduced 0.2%	1,987 $423,000
Q1 2021 May 14, 2021	BUY	$221.91 - $258.6 $17,752 - $20,688	80 Added 4.19%	1,991 $495,000
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $60,586 - $72,147	280 Added 17.17%	1,911 $439,000
Q3 2020 Nov 12, 2020	SELL	$234.65 - $260.95 $11,028 - $12,264	-47 Reduced 2.8%	1,631 $415,000
Q2 2020 Aug 17, 2020	SELL	$197.81 - $242.74 $593 - $728	-3 Reduced 0.18%	1,678 $396,000
Q1 2020 May 13, 2020	SELL	$182.24 - $241.7 $18,770 - $24,895	-103 Reduced 5.77%	1,681 $341,000
Q4 2019 Feb 12, 2020	SELL	$189.21 - $243.2 $7,568 - $9,728	-40 Reduced 2.19%	1,784 $430,000
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $11,669 - $13,678	-70 Reduced 3.7%	1,824 $336,000
Q1 2019 May 14, 2019	SELL	$180.87 - $203.88 $1,266 - $1,427	-7 Reduced 0.37%	1,894 $360,000
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $43,172 - $50,396	242 Added 14.59%	1,901 $370,000
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $2,779 - $3,133	-15 Reduced 0.9%	1,659 $344,000
Q2 2017 Aug 11, 2017	BUY	N/A	1,674	1,674 $288,000

Others Institutions Holding AMGN

# of Institutions

3,289

Shares Held

439M

Call Options Held

6.26M

Put Options Held

7.38M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $159B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cheviot Value Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cheviot Value Management, LLC with notifications on news.

Account

Cheviot Value Management, LLC Amgen Inc Transaction History